• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OSTEOMED EXTREMILOCK FOOT PLATING SYSTEM; 2.7MM X 30MM DOUBLE-LEAD LOCKING SCREW, T8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OSTEOMED EXTREMILOCK FOOT PLATING SYSTEM; 2.7MM X 30MM DOUBLE-LEAD LOCKING SCREW, T8 Back to Search Results
Catalog Number 338-2730
Device Problem Metal Shedding Debris (1804)
Patient Problem Toxicity (2333)
Event Date 08/15/2017
Event Type  Injury  
Manufacturer Narrative
Neither the plate (2.7mm - 5 hole straight plate, p/n 336-2700), screws (2.7mm locking screws, double lead, p/n's 338-2728 & 338-2730), nor any of the fragments of the reported debris, were returned to osteomed for examination.The complaint that there was debris suspected to be metallosis found near the implant could not be confirmed.Therefore, no root cause could be determined.Metallosis is the medical condition involving deposition and build-up of metal debris in the soft tissues of the body.Metallosis has been hypothesized to occur when metallic components in medical implants, generally joint replacements, grind against one another.The patient had no other metal implants in proximity to the plate (and screws) in question.The extremilock foot plating system ifu, p/n 030-1826, provides a warning not to allow implants of dissimilar metals to be used together in or near the implant site.None of the implants involved in this complaint were reported with their lot numbers, therefore, no review of the related dhrs were possible.A two-year review of capas did not identify any capa investigations for this device.Due to the nature of this complaint, and the information available, a review of the ncrs is not applicable.The review of the complaint history for this implant shows that this is the first complaint ever received for this device.This issue will be monitored through routine trending.
 
Event Description
On (b)(4) 2017, osteomed was notified of a case using extremilock foot in which the patient was suspected to have metallosis.No part numbers were provided at that time (b)(4).On (b)(4) 2017, we received notification of this device used within the case - p/n 338-2730.Per information from the distributor, this was observed during routine implant removal following healing of the fracture site.There were no other metal implants in proximity of the plate in question.The patient was not tested for metal sensitivity, and the patient had no symptoms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXTREMILOCK FOOT PLATING SYSTEM
Type of Device
2.7MM X 30MM DOUBLE-LEAD LOCKING SCREW, T8
Manufacturer (Section D)
OSTEOMED
3885 arapaho road
addison TX 75001
Manufacturer (Section G)
OSTEOMED
3885 arapaho road
addison TX 75001
Manufacturer Contact
latoia phillips
3885 arapaho road
addison, TX 75001
MDR Report Key6962130
MDR Text Key89740869
Report Number2027754-2017-00012
Device Sequence Number1
Product Code HRS
Combination Product (y/n)N
Reporter Country CodeID
PMA/PMN Number
K131445
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Type of Report Initial
Report Date 10/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Catalogue Number338-2730
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-